EUVIMEDSkopri EUVIMED
KorrekturOpen access · CC BY 4.0

Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”

Advanced Science · 2026-06 · 13 (33)

DOI: 10.1002/advs.75571 ↗

At a glance

Korrektur in Advanced Science, published online on 2026-05-07. The full text is freely available (open access, CC BY 4.0).

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Ebda abstract disponibbli.

Cite

APA

(2026). Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science, 13(33). https://doi.org/10.1002/advs.75571

Vancouver

Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science. 2026;13(33). doi:10.1002/advs.75571

BibTeX
@article{euvimed2026,
  title = {Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {33},
  doi = {10.1002/advs.75571}
}
Start for free →